Standard Biotools (LAB) Non-Current Debt (2010 - 2023)

Standard Biotools (LAB) has 5 years of Non-Current Debt data on file, last reported at $3.4 million in Q4 2023.

• On a quarterly basis, Non-Current Debt fell 58.34% year-over-year to $3.4 million in Q4 2023; TTM through Dec 2023 was $3.4 million, a 58.34% decrease from a year earlier, with the FY2023 full-year figure at $3.4 million, down 58.34% from the prior year.
• Non-Current Debt for Q4 2023 stood at $3.4 million, down from $4.6 million in the prior quarter.
• Over the last five years, Non-Current Debt for LAB reached as high as $10.2 million in Q2 2022 and fell as low as $3.4 million in Q4 2023.
• Historically, Non-Current Debt has averaged $7.9 million across 3 years, with a median of $8.8 million in 2022.
• Across the five-year window, Non-Current Debt dropped 6.14% in 2022 and tumbled 58.34% in 2023, its largest moves.
• Year by year, Non-Current Debt stood at $10.0 million in 2021, then slipped by 18.46% to $8.2 million in 2022, then sank by 58.34% to $3.4 million in 2023.
• Per Business Quant data, the three most recent Non-Current Debt figures were $3.4 million in Q4 2023, $4.6 million in Q3 2023, and $5.8 million in Q2 2023.